Masakazu Notsu

732 citations

39 papers · 558 indexed · h-index 15

Molecular Biology
Endocrinology, Diabetes and Metabolism top 10%
Orthopedics and Sports Medicine top 5%
Oncology
Surgery

Co-authors: Toshitsugu Sugimoto Ippei Kanazawa Ayumu Takeno Ken‐ichiro Tanaka Toru Yamaguchi Ken-ichiro Tanaka Mika Yamauchi Masahiro Yamamoto
Topics: Bone Metabolism and Diseases (15 papers)Bone health and treatments (10 papers)Bone health and osteoporosis research (9 papers)
Cited by: Orthopedics and Sports Medicine Clinical Biochemistry Endocrinology, Diabetes and Metabolism
Journals: The Journal of Clinical Endocrinology & Metabolism Biochemical and Biophysical Research Communications International Journal of Molecular Sciences
Partner nations: Japan

In The Last Decade

Masakazu Notsu

38 papers receiving 550 citations

Peers

Countries citing papers authored by Masakazu Notsu

Since Specialization

Citations

This map shows the geographic impact of Masakazu Notsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masakazu Notsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masakazu Notsu more than expected).

Fields of papers citing papers by Masakazu Notsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masakazu Notsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masakazu Notsu. The network helps show where Masakazu Notsu may publish in the future.

Co-authorship network of co-authors of Masakazu Notsu

This figure shows the co-authorship network connecting the top 25 collaborators of Masakazu Notsu. A scholar is included among the top collaborators of Masakazu Notsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masakazu Notsu. Masakazu Notsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association Between Papillary Thyroid Carcinoma and Vertebral Fracture 2023 ·Hormone and Metabolic Research ·(unknown),Masakazu Notsu,Mika Yamauchi,(unknown),Keizo Kanasaki	1
2	Graves’ disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature 2023 ·BMC Endocrine Disorders ·(unknown),Masakazu Notsu,(unknown),(unknown),Kazuhiko Uchida,Keizo Kanasaki	7
3	Graves’ disease and vertebral fracture: Possible pathogenic link in postmenopausal women 2020 ·Clinical Endocrinology ·(unknown),Masakazu Notsu,Mika Yamauchi,(unknown),Toshitsugu Sugimoto,Keizo Kanasaki	8
4	High glucose promotes mineralization via bone morphogenetic protein 4-Smad signals in early stage of osteoblast differentiation 2020 ·Diabetology International ·Ayumu Takeno,Ippei Kanazawa,Ken‐ichiro Tanaka,Masakazu Notsu,Keizo Kanasaki,Takamasa Oono,Yoshihiro Ogawa,Toshitsugu Sugimoto	10
5	A case of insulin-like growth factor 2-producing gastrointestinal stromal tumor with severe hypoglycemia 2020 ·BMC Endocrine Disorders ·(unknown),(unknown),Miwa Morita,Hitomi Miyake,Masahiro Yamamoto,Hiroki Sonoyama,Sayuri Tanaka,Masakazu Notsu,Mika Yamauchi,Yusuke Fujii,Noriyoshi Ishikawa,Izumi Fukuda,Shunji Ishihara,Keizo Kanasaki	10
6	A scoring assessment tool for the risk of vertebral fractures in patients with type 2 diabetes mellitus 2019 ·Bone ·Ippei Kanazawa,Ken-ichiro Tanaka,(unknown),Masakazu Notsu,Hitomi Miyake,Toshitsugu Sugimoto	6
7	Phloretin Suppresses Bone Morphogenetic Protein-2-Induced Osteoblastogenesis and Mineralization via Inhibition of Phosphatidylinositol 3-kinases/Akt Pathway 2019 ·International Journal of Molecular Sciences ·Ayumu Takeno,Ippei Kanazawa,Ken‐ichiro Tanaka,Masakazu Notsu,Toshitsugu Sugimoto	19
8	Papillary thyroid carcinoma is a risk factor for severe osteoporosis 2019 ·Journal of Bone and Mineral Metabolism ·Masakazu Notsu,Mika Yamauchi,Miwa Morita,(unknown),Toshitsugu Sugimoto	9
9	Bazedoxifene Ameliorates Homocysteine-Induced Apoptosis via NADPH Oxidase-Interleukin 1β and 6 Pathway in Osteocyte-like Cells 2019 ·Calcified Tissue International ·Masakazu Notsu,Ippei Kanazawa,Ayumu Takeno,Ken‐ichiro Tanaka,Toshitsugu Sugimoto	2
10	Phloretin Promotes Adipogenesis via Mitogen-Activated Protein Kinase Pathways in Mouse Marrow Stromal ST2 Cells 2018 ·International Journal of Molecular Sciences ·Ayumu Takeno,Ippei Kanazawa,Masakazu Notsu,Ken‐ichiro Tanaka,Toshitsugu Sugimoto	21
11	Acute suppurative thyroiditis caused by thyroid papillary carcinoma in the right thyroid lobe of a healthy woman 2018 ·Thyroid Research ·(unknown),Masakazu Notsu,(unknown),Miwa Morita,Masahiro Yamamoto,Mika Yamauchi,(unknown),Ichiro Morikura,(unknown),Hideyuki Kawauchi,(unknown),Asuka Araki,Noriyoshi Ishikawa,Riruke Maruyama,Toshitsugu Sugimoto	2
12	Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus 2018 ·Osteoporosis International ·Ippei Kanazawa,Masakazu Notsu,(unknown),Ken-ichiro Tanaka,Toshitsugu Sugimoto	21
13	Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells 2017 ·Calcified Tissue International ·Masakazu Notsu,Ippei Kanazawa,Ayumu Takeno,Maki Yokomoto‐Umakoshi,Ken‐ichiro Tanaka,Toru Yamaguchi,Toshitsugu Sugimoto	25
14	Visceral fat obesity increases serum DPP-4 levels in men with type 2 diabetes mellitus 2016 ·Diabetes Research and Clinical Practice ·Sayuri Tanaka,Ippei Kanazawa,Masakazu Notsu,Toshitsugu Sugimoto	15
15	Long-term efficacy and safety of vildagliptin add-on therapy in type 2 diabetes mellitus with insulin treatment 2016 ·Diabetes Research and Clinical Practice ·Ippei Kanazawa,Ken-ichiro Tanaka,Masakazu Notsu,Sayuri Tanaka,(unknown),(unknown),Yuko Yamane,Yuko Tada,Motofumi Sasaki,Mika Yamauchi,Toshitsugu Sugimoto	20
16	Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report 2016 ·BMC Endocrine Disorders ·Ayumu Takeno,Masahiro Yamamoto,Masakazu Notsu,(unknown)	13
17	Activation of AMP-activated protein kinase protects against homocysteine-induced apoptosis of osteocytic MLO-Y4 cells by regulating the expressions of NADPH oxidase 1 (Nox1) and Nox2 2015 ·Bone ·Ayumu Takeno,Ippei Kanazawa,Ken‐ichiro Tanaka,Masakazu Notsu,(unknown),Toru Yamaguchi,Toshitsugu Sugimoto	33
18	Activation of AMP-activated protein kinase decreases receptor activator of NF-κB ligand expression and increases sclerostin expression by inhibiting the mevalonate pathway in osteocytic MLO-Y4 cells 2015 ·Biochemical and Biophysical Research Communications ·Maki Yokomoto‐Umakoshi,Ippei Kanazawa,Ayumu Takeno,Ken‐ichiro Tanaka,Masakazu Notsu,Toshitsugu Sugimoto	17
19	[Secondary osteoporosis or secondary contributors to bone loss in fracture. Effects of oxidative stress on bone metabolism]. 2013 ·PubMed ·Masakazu Notsu,Toru Yamaguchi	6
20	Advanced Glycation End Products (AGEs), but not High Glucose, Inhibit the Osteoblastic Differentiation of Mouse Stromal ST2 Cells Through the Suppression of Osterix Expression, and Inhibit Cell Growth and Increasing Cell Apoptosis 2012 ·Calcified Tissue International ·(unknown),Toru Yamaguchi,Ken-ichiro Tanaka,Masakazu Notsu,(unknown),Shozo Yano,Toshitsugu Sugimoto	78

About Masakazu Notsu

Masakazu Notsu is a scholar working on Orthopedics and Sports Medicine, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 39 papers that have together received 558 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (15 papers), Bone health and treatments (10 papers) and Bone health and osteoporosis research (9 papers). The work is most often cited by research in Orthopedics and Sports Medicine (140 citations), Clinical Biochemistry (75 citations) and Endocrinology, Diabetes and Metabolism (151 citations). Masakazu Notsu has collaborated with scholars based in Japan. Frequent co-authors include Toshitsugu Sugimoto, Ippei Kanazawa, Ayumu Takeno, Ken‐ichiro Tanaka, Toru Yamaguchi, Ken-ichiro Tanaka, Mika Yamauchi, Masahiro Yamamoto, Shozo Yano and Sayuri Tanaka. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact